Xylem Inc. (NYSE:XYL) Shares Bought by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. raised its stake in Xylem Inc. (NYSE:XYLFree Report) by 6.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,052 shares of the industrial products company’s stock after acquiring an additional 546 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in Xylem were worth $1,050,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in XYL. Public Sector Pension Investment Board increased its position in shares of Xylem by 77.3% in the second quarter. Public Sector Pension Investment Board now owns 9,410 shares of the industrial products company’s stock valued at $1,276,000 after buying an additional 4,103 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Xylem by 38.2% in the second quarter. AQR Capital Management LLC now owns 28,887 shares of the industrial products company’s stock valued at $3,918,000 after buying an additional 7,981 shares in the last quarter. Daymark Wealth Partners LLC increased its position in shares of Xylem by 32.1% in the second quarter. Daymark Wealth Partners LLC now owns 2,802 shares of the industrial products company’s stock valued at $380,000 after buying an additional 681 shares in the last quarter. MBB Public Markets I LLC purchased a new stake in shares of Xylem in the second quarter valued at approximately $2,307,000. Finally, The Manufacturers Life Insurance Company increased its position in shares of Xylem by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 153,978 shares of the industrial products company’s stock valued at $20,885,000 after buying an additional 844 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Performance

NYSE XYL opened at $121.53 on Monday. The stock’s fifty day moving average is $120.88 and its two-hundred day moving average is $128.32. The firm has a market capitalization of $29.53 billion, a P/E ratio of 35.54, a price-to-earnings-growth ratio of 2.05 and a beta of 1.06. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. Xylem Inc. has a fifty-two week low of $111.72 and a fifty-two week high of $146.08.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.11. The company had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.99 earnings per share. On average, research analysts anticipate that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 1.18%. The ex-dividend date was Tuesday, November 26th. Xylem’s dividend payout ratio (DPR) is presently 42.11%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on XYL. TD Cowen cut their price objective on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research report on Wednesday, November 6th. Citigroup dropped their price target on Xylem from $148.00 to $147.00 and set a “buy” rating for the company in a research report on Monday, January 13th. Robert W. Baird dropped their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Stifel Nicolaus dropped their price target on Xylem from $166.00 to $150.00 and set a “buy” rating for the company in a research report on Friday. Finally, Royal Bank of Canada dropped their price target on Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $150.50.

Check Out Our Latest Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.